super ace win

super ace win

AUSTIN, Texas (AP) — Any Texas or Texas A&M player has heard the lore of the rivalry between the two schools, a grudge match that dates to 1894. But for more than a decade — two generations of college football players — that's all it has been: Ghostly memories of great games and great plays made by heroes of the distant past.Stock market today: Rising tech stocks pull Wall Street to another recordTRACCOM INC. (Pink Open Market Symbol: TRCC) COMPLETES ACQUISITION OF VULCAIN, INC.Bengals quarterback Joe Burrow had another limited practice Thursday as the team readies for Saturday’s game against the Broncos. Burrow, though, does not have an injury designation. He is listed with injuries to his right wrist and a knee. Burrow has been on the injury report with the wrist injury all season after undergoing surgery on it last season. He said earlier this week that the wrist no longer bothers him. “I don’t think about it a ton right now,” Burrow said, via Jay Morrison of USA Today. “I think we’re pretty much past it. There are still arm care and things that I do to help with that, but we’re in a good spot.” Burrow is a leading candidate for comeback player of the year with his 4,229 passing yards leading the league as do his 39 touchdown passes.

Anne-Mette Elkjær Andersen Joins Tannenbaum Helpern as Partner in the Firm's Corporate Practice Group

Hawkins stock soars to all-time high of $135.7 amid robust growth

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Dec 18, 2024-- Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference being held Jan. 13-16, 2025, in San Francisco. The management team will present at the conference beginning at 2:15 p.m. PT on Tuesday, Jan. 14, 2025. A live audio webcast of the presentation will be available at the investor relations section of the Company’s website, at ir.ardenthealth.com , and a replay will be available for 90 days using the same link. In conjunction with the conference, the Ardent management team will be available to participate in one-on-one meetings with investors registered to attend the conference. Interested investors should contact their J.P. Morgan representative to schedule meetings. About Ardent Health Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,800 affiliated providers across six states. For more information, please visit ardenthealth.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20241218439414/en/ CONTACT: Investor Contact: Dave Styblo Investor.Relations@ardenthealth.com (615) 296-3016Media Contact: Rebecca Kirkham rebecca.kirkham@ardenthealth.com (615) 296-3635 KEYWORD: CALIFORNIA TENNESSEE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: MANAGED CARE HOSPITALS GENERAL HEALTH HEALTH SOURCE: Ardent Health Copyright Business Wire 2024. PUB: 12/18/2024 04:30 PM/DISC: 12/18/2024 04:28 PM http://www.businesswire.com/news/home/20241218439414/en

Thunder vs Pacers free live streams without cable on Fan Duel Sports Network | Sporting News

Live Music Market to Expand by USD 35.56 Billion (2024-2028), Driven by Rising Demand for Experiences, AI Redefining the Market Landscape - Technavio

( MENAFN - GlobeNewsWire - Nasdaq) RIMOUSKI, Québec, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the“Company” or“Puma”) announces that it has closed a non-brokered placement (the“FT Private Placement”) consisting of 6,685,000 flow-through units (the“FT Units”) at $0.10 per FT Unit for gross proceeds of C$668,500. Each FT Unit comprises one flow-through share and one common share purchase warrant (“Warrant”). Each Warrant is exercisable to purchase one common share of the Company at $0.15 per share valid for 24 months. The Warrants are subject to an acceleration clause that entitles the Company to provide notice (the "Acceleration Notice") to holders that they will expire 30 days from the date the Company delivers the Acceleration Notice. The Company can only provide the Acceleration Notice if the closing price of the Company's Common Shares on the TSXV is equal to or greater than $0.25 for 30 consecutive trading days. The Acceleration Notice can be provided at any time after the statutory hold period and before the expiry date of the warrants. All securities issued in connection with the Private Placement are subject to a hold period of four months and one day pursuant to applicable securities laws. The net proceeds of the FT units will be used to incur eligible Canadian exploration expenses and flow-through mining expenditures, as defined under the Income Tax Act (Canada), that will be renounced in favour of the purchasers, with an effective date of no later than Dec. 31, 2025. The funds will advance the exploration of the newly acquired McKenzie Gold Project and other company assets in northern New Brunswick. In connection with the closing of the private placement offerings, the company paid aggregate cash finder's fees of $39,445 and issued 394,450 non-transferable finder warrants. The finder warrants have the same terms than the warrants included in the units and exercisable at $0.15 per common share. Certain directors and other insiders of the Company participated in the Private Placement. They subscribed for 350,000 FT Units for an aggregate price of $35,000, an amount no more than the maximum amount permissible under applicable securities laws and regulatory rules. Participation by the directors and other insiders in the Private Placement is considered a "related party transaction" under Multilateral Instrument 61- 101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is exempt from the requirements to obtain a formal valuation and minority shareholder approval in connection with the insiders' participation in the Private Placement in reliance on sections 5.5(a) and 5.7(1)(a) of MI 61-101 in that the fair market value (as determined under MI 61-101) of any securities issued under the Private Placement (and the consideration paid to the Company therefor) to interested parties (as defined under MI 61-101) did not exceed 25% of the Company's market capitalization (as determined under MI 61-101). Qualified Person The content of this press release was prepared by Marcel Robillard, President, who supervised the preparation of the information that forms part of this news release. About Puma's Assets in New Brunswick Puma has accumulated an impressive portfolio of prospective gold landholdings strategically located close to roads and infrastructure in Northern New Brunswick - the Williams Brook Project and the new McKenzie Gold Project. Both are located near the Rocky Brook Millstream Fault (“RBMF”), a major regional structure formed during the Appalachian Orogeny and a significant control for gold deposition in the region. Puma's work to date has focused on the Williams Brook property, but prospecting and surface exploration work on its other properties have confirmed their potential for significant gold mineralization. About Puma Exploration Puma Exploration is a Canadian mineral exploration company focused on finding and growing a pipeline of precious metals projects in New Brunswick, near Canada's Famous Bathurst Mining Camp. Puma has a long history in Northern New Brunswick, having worked on regional projects for over 15 years. Puma's successful exploration methodology, which combines old prospecting methods with detailed trenching and up-to-date technology such as Artificial Intelligence, has been instrumental in facilitating an understanding of the region's geology and associated mineralized systems. Armed with geophysical surveys, geochemical data and consultants' expertise, Puma has developed a perfect low-cost exploration tool to discover gold at shallow depths and maximize drilling results. The Company is committed to its DEAR business model of D iscovery, E xploration, A cquisition and R oyalties to generate maximum value for shareholders with low share dilution. Connect with us on Facebook / X / LinkedIn . Visit for more information or contact: Marcel Robillard , President and CEO. (418) 750-8510; ... Mia Boiridy , Head of Investor Relations and Corporate Development. (250) 575-3305; ... Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements: This press release may contain forward-looking statements. Such forward-looking statements involve several known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of Puma to be materially different from actual future results and achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made, except as required by law. Puma undertakes no obligation to publicly update or revise any forward-looking statements. The quarterly and annual reports and the documents submitted to the securities administration describe these risks and uncertainties. MENAFN24122024004107003653ID1109028412 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.AI Virtual Assistants Market Is Booming So Rapidly | Google Assistant, Amazon Alexa, Apple SiriUS lawmakers concluded a two-year investigation Monday into the Covid-19 outbreak that killed 1.1 million Americans -- backing the theory that the virus likely leaked from a Chinese laboratory. A 520-page report from the Republican-controlled House Select Subcommittee on the Coronavirus Pandemic looked at the federal and state-level response, as well as the pandemic's origins and vaccination efforts. "This work will help the United States, and the world, predict the next pandemic, prepare for the next pandemic, protect ourselves from the next pandemic, and hopefully prevent the next pandemic," panel chairman Brad Wenstrup said in a letter to Congress. US federal agencies, the World Health Organization and scientists across the planet have arrived at different conclusions about the most likely origin of Covid-19, and no consensus has emerged. Most believe it to have spread from animals in China, but a US intelligence analysis said last year that the virus may have been genetically engineered and escaped from a virology lab in the Chinese city of Wuhan, where human cases first emerged. The congressional panel was persuaded by the lab leak theory after meeting 25 times, conducting more than 30 transcribed interviews and reviewing more than one million pages of documents. The investigation included two days of interviews behind closed doors with Anthony Fauci, the government scientist who became the nation's most trusted expert in the chaotic early days of the 2020 outbreak. Fauci's clashes with former and incoming president Donald Trump over the response sparked fury on the right, and he now lives with security protection following death threats against his family. More from this section Republicans accuse the 83-year-old immunologist of helping to set off the worst pandemic in a century by approving funding passed on to Chinese scientists they accuse of manufacturing the SARS-CoV-2 coronavirus that causes Covid-19. Among its headline conclusions, the report said the National Institutes of Health had indeed funded contentious "gain-of-function" research -- which seeks to enhance viruses as a way of finding ways to combat them -- at the Wuhan Institute of Virology. Fauci angrily denied covering up the origins of Covid-19 before the panel in June, arguing that it would be "molecularly impossible" for the bat viruses studied at the lab to be turned into the virus that caused the pandemic. But the panel's report said SARS-CoV-2 "likely emerged because of a laboratory or research related accident." The probe found that lockdowns "did more harm than good" and that mask mandates were "ineffective at controlling the spread of Covid-19," contradicting other research showing that masking in public does reduce transmission rates. Social distancing guidelines also came under criticism, although travel restrictions were deemed to have saved lives. Investigators found that Trump's Operation Warp Speed -- the publicly-funded project to develop Covid vaccines -- was a "tremendous success" but that school closures would have an "enduring impact" on US children. ft/jgc